Regulation of Immune Responses by Histone Deacetylase Inhibitors
Open accessThe DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.
Abstract
Both genetic and epigenetic factors are important regulators of the immune system. There is an increasing body of evidence attesting to epigenetic modifications that influence the development of distinct innate and adaptive immune response cells. Chromatin remodelling via acetylation, methylation, phosphorylation, and ubiquitination of histone proteins as well as DNA, methylation is epigenetic mechanisms by which immune gene expression can be controlled. In this paper, we will discuss the role of epigenetics in the regulation of host immunity, with particular emphasis on histone deacetylase inhibitors. In particular, the role of HDAC inhibitors as a new class of immunomodulatory therapeutics will also be reviewed.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
NF-κB regulation in the immune system
Li, Q., & Verma, I. M. (2002) · Nature Reviews Immunology · doi:10.1038/nri910 · Cited by 4,007
Anticancer activities of histone deacetylase inhibitors
Bolden, J. E., Peart, M. J., & Johnstone, R. W. (2006) · Nature Reviews Drug Discovery · doi:10.1038/nrd2133 · Cited by 2,919 · cited 2×
“to chromatin structure and function [1, 2].”
BackgroundHistone deacetylases and cancer: causes and therapies
Marks, P. A., Rifkind, R. A., Richon, V. M., Breslow, R., Miller, T., & Kelly, W. K. (2001) · Nature reviews. Cancer · doi:10.1038/35106079 · Cited by 1,866 · cited 1×
“Altered HDAC function and recruitment could result in enhanced hypoacetylation and repression of genes required for normal growth and development and disruption of the HDAC/HAT balance favouring abnormal acetylation and inappropriate protein expression could provide the molecular trigger that directs pathological outc…”
BackgroundT Helper Cell Fate Specified by Kinase-Mediated Interaction of T-bet with GATA-3
Hwang, E. S., Szabo, S. J., Schwartzberg, P. L., & Glimcher, L. H. (2005) · Science · doi:10.1126/science.1103336 · Cited by 519 · cited 1×
“The fact that T-bet can bind directly with GATA-3 to inhibit this activity ensures a balance between these Th lymphocyte functions [30].”
BackgroundRahman, I., Marwick, J., & Kirkham, P. (2004) · Biochemical Pharmacology · doi:10.1016/j.bcp.2004.05.042 · Cited by 507
The histone deacetylase HDAC11 regulates the expression of interleukin 10 and immune tolerance
Villagra, A., Cheng, F., Wang, H.-W., Suarez, I., Glozak, M., Maurin, M., Nguyen, D., Wright, K. L., Atadja, P. W., Bhalla, K., et al. (2009) · Nature Immunology · doi:10.1038/ni.1673 · Cited by 455
Roger, T., Lugrin, J., Le Roy, D., Goy, G., Mombelli, M., Koessler, T., Ding, X. C., Chanson, A.-L., Reymond, M. K., Miconnet, I., et al. (2011) · Blood · doi:10.1182/blood-2010-05-284711 · Cited by 341 · cited 1×
“Recent studies have shown that HDAC inhibition by TSA, SAHA, and VPA can impair innate immune responses to TLR agonists by reducing the expression of genes associated with microbial sensing (C-type lectins, adhesion molecules, and others) as well as a range of cytokine and chemokine genes [69], thereby increasing susc…”
BackgroundActivation of MHC Class I, II, and CD40 Gene Expression by Histone Deacetylase Inhibitors
Magner, W. J., Kazim, A. L., Stewart, C., Romano, M. A., Catalano, G., Grande, C., Keiser, N., Santaniello, F., & Tomasi, T. B. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.165.12.7017 · Cited by 294 · cited 1×
“HDACi such as sodium butyrate, TSA, and trapoxin A among others upregulate MHC class I and class II proteins, CD40, CD80, and CD86 antigens necessary for costimulation, as well as adhesion molecules such as intercellular adhesion molecule-1 (ICAM-1) on acute myeloid leukemic (AML) cells, human neuroblastoma tumour cel…”
BackgroundBahn, S., Mimmack, M., Ryan, M., Caldwell, M. A., Jauniaux, E., Starkey, M., Svendsen, C. N., & Emson, P. (2002) · The Lancet · doi:10.1016/s0140-6736(02)07497-4 · Cited by 211
Wells, A. D. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0803917 · Cited by 153 · cited 1×
“This occurs as a result of epigenetic imprinting that can be inherited over multiple cell division cycles [36].”
Background
Cited by
Kumar, V., Kundu, S., Singh, A., & Singh, S. (2022) · Current Neuropharmacology · doi:10.2174/1570159x19666210609160017 · Cited by 210
“The blockade of HDAC11 via its specific inhibitors will be a novel approach for the treatment of Parkinson's disease [123].”
BackgroundCleophas, M. C. P., Crişan, T. O., Lemmers, H., Toenhake-Dijkstra, H., Fossati, G., Jansen, T. L., Dinarello, C. A., Netea, M. G., & Joosten, L. A. B. (2016) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2014-206258 · Cited by 139
Targeting the acetylation signaling pathway in cancer therapy
Dang, F., & Wei, W. (2022) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2021.03.001 · Cited by 109
Metadata
- Authors
- Licciardi, P. V., & Karagiannis, T. C.
- Venue
- ISRN Hematology
- Publisher
- Wiley
- Published
- 2012-03-18
- Volume
- 2012
- Pages
- 1-10
- ISSN
- 2090-441X (ISSN-L)
- 2090-4428
- OpenAlex
- W2026838378
- Cited by
- 75
- References
- 11
- FWCI
- 1.28
- Type
- journal article
- Language
- en
- Open access
- diamond
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Regulation of Immune Responses by Histone Deacetylase Inhibitors. https://app.cochat.ai/papers/10.5402/2012/690901
- The paper
- Licciardi, P. V., & Karagiannis, T. C. (2012). Regulation of Immune Responses by Histone Deacetylase Inhibitors. ISRN Hematology. https://doi.org/10.5402/2012/690901
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.